1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Scilex Holding Company

Scilex Holding Company

SCLX
Scilex Holding CompanyUS flagNASDAQ Capital Market
8.07
USD
+0.26
- -
68.52MMarket Cap

Total Valuation

Scilex Holding Company carries a market capitalization of 68.52M, placing it among publicly traded companies globally. Its enterprise value stands at 156.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap68.52M
Enterprise Value156.55M

Share Statistics

Scilex Holding Company currently has 7.03M shares outstanding.

Shares Outstanding7.03M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.97, and the price-to-book ratio stands at -0.07.

PE RatioN/A
PS Ratio1.97
PB Ratio-0.07
P/TBV Ratio-0.17
P/FCF Ratio330.69
P/OCF Ratio-20.25

Enterprise Valuation

EV / Sales4.62
EV / EBITDAN/A
EV / EBITN/A
EV / FCF17.05

Financial Position

Scilex Holding Company maintains a current ratio of 0.08, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -38.56, indicating conservative leverage, while an interest coverage ratio of -30.08 demonstrates limited ability to service its debt obligations.

Current Ratio0.08
Quick Ratio0.07
Debt / Equity-38.56
Debt / EBITDA-0.36
Interest Coverage-30.08

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-201.78
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.62

Taxes

Income Tax26,000.00
Effective Tax RateN/A

Stock Price Statistics

Scilex Holding Company's stock has gained approximately 29.12% over the past 52 weeks. The 50-day moving average sits at 5.33, while the 200-day moving average is 7.65.

Beta (5Y)N/A
52-Week Price Change29.12%
50-Day Moving Average5.33
200-Day Moving Average7.65
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Scilex Holding Company generated 33.86M in revenue and converted that into -375.92M in net income, yielding earnings per share of -39.24. EBITDA reached -270.09M, while operating income came in at -276.57M.

Revenue33.86M
Gross Profit20.20M
Operating Income-276.57M
Pretax Income-393.60M
Net Income-375.92M
EBITDA-270.09M
EBIT-276.57M
Earnings Per Share (EPS)-39.24

Balance Sheet

Scilex Holding Company holds 3.36M in cash and equivalents against 97.96M in total debt, resulting in a net debt position of 80.20M. Total book value stands at -965.05M, with working capital of -459.78M providing operational flexibility.

Cash & Cash Equivalents3.36M
Total Debt97.96M
Net Debt80.20M
Equity (Book Value)-965.05M
Book Value Per Share-96.22
Working Capital-459.78M

Cash Flow

Scilex Holding Company produced -3.30M in operating cash flow over the past twelve months. After subtracting -3.50M in capital expenditures, free cash flow totaled -6.80M - equivalent to -0.68 per share.

Operating Cash Flow-3.30M
Capital Expenditures-3.50M
Free Cash Flow-6.80M
FCF Per Share-0.68

Margins

Scilex Holding Company operates with a gross margin of 59.65, reflecting its pricing power and cost economics. The operating margin of -816.77 and net profit margin of -1,110.16 provide insight into operational efficiency.

Gross Margin59.65
Operating Margin-816.77
Pretax Margin-1,162.36
Profit Margin-1,110.16
EBITDA Margin-797.61

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-10.13
FCF Yield0.30

Stock Splits

Scilex Holding Company's most recent stock split took place on April 15, 2025 with a 35:1 split ratio.

Last Split Date4/15/2025
Split Ratio35:1

Scores

Scilex Holding Company posts an Altman Z-Score of -17.88, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-17.88